Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1999;33:740-745

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Healy, D. P.
Right arrow Articles by Song, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Healy, D. P.
Right arrow Articles by Song, L.
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*High Blood Pressure
Related Collections
Right arrow ACE/Angiotension receptors
Right arrow Animal models of human disease
Right arrow Hypertension - basic studies

(Hypertension. 1999;33:740-745.)
© 1999 American Heart Association, Inc.


Scientific Contribution

Kidney Aminopeptidase A and Hypertension, Part I

Spontaneously Hypertensive Rats

Dennis P. Healy; Lijun Song

From the Department of Pharmacology, Mount Sinai School of Medicine of the City University of New York, New York, NY.

Correspondence to Dr Dennis P. Healy, Department of Pharmacology, Box 1215, Mount Sinai School of Medicine, One Gustave L. Levy Pl, New York, NY 10029. E-mail d_healy{at}smtplink.mssm.edu

Abstract—Tissue and plasma levels of aminopeptidase A (APA), the principal enzyme that hydrolyzes angiotensin II (Ang II) to angiotensin III, were measured in spontaneously hypertensive rats (SHR) and their normotensive control strain at 3 different ages corresponding to prehypertensive (4 weeks), developing (8 weeks), and established (16 weeks) phases of hypertension. Plasma APA activity was significantly but modestly elevated in SHR at all 3 ages compared with normotensive Wistar-Kyoto rats. Likewise, levels of APA in brain, heart, and adrenal gland were generally, but again only moderately, elevated in SHR at all ages. However, a large increase in APA activity was seen within the kidney in which APA levels were elevated 41%, 51%, and 68% in SHR at 4, 8, and 16 weeks of age, respectively. Kidney APA levels were also significantly increased in immunoblots from 8- and 16-week-old SHR. Glomeruli isolated from 16-week-old SHR had 57% higher APA activity and increased immunoreactivity compared with Wistar-Kyoto rats. To determine whether the increase in kidney APA activity in SHR was related to Ang II levels, SHR were treated for 2 weeks with the angiotensin-converting enzyme inhibitor captopril. Captopril treatment reduced blood pressure to normotensive values and resulted in a 25% reduction in kidney APA activity. These results suggest that APA expression in the kidney may be regulated by activity of the renin-angiotensin system. If so, this would further suggest that upregulation of APA during conditions in which Ang II levels were elevated would have a protective effect against Ang II–mediated cardiovascular diseases, whereas a decrease in APA expression or a failure to upregulate would exacerbate such conditions.


Key Words: aminopeptidases • angiotensin II • angiotensin III • hypertension • kidney • kidney glomerulus




This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
T. Pisitkun, R.-F. Shen, and M. A. Knepper
Identification and proteomic profiling of exosomes in human urine
PNAS, September 7, 2004; 101(36): 13368 - 13373.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
K. Ino, C. Uehara, F. Kikkawa, H. Kajiyama, K. Shibata, T. Suzuki, E. E. Khin, M. Ito, M. Takeuchi, A. Itakura, et al.
Enhancement of Aminopeptidase A Expression during Angiotensin II-Induced Choriocarcinoma Cell Proliferation through AT1 Receptor Involving Protein Kinase C- and Mitogen-Activated Protein Kinase-Dependent Signaling Pathway
J. Clin. Endocrinol. Metab., August 1, 2003; 88(8): 3973 - 3982.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
H.-C. Chen, J. L. Bouchie, A. S. Perez, A. C. Clermont, S. Izumo, J. Hampe, and E. P. Feener
Role of the Angiotensin AT1 Receptor in Rat Aortic and Cardiac PAI-1 Gene Expression
Arterioscler. Thromb. Vasc. Biol., October 1, 2000; 20(10): 2297 - 2302.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
M. Troyanovskaya, G. Jayaraman, L. Song, and D. P. Healy
Aminopeptidase-A. I. cDNA cloning and expression and localization in rat tissues
Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2000; 278(2): R413 - R424.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
Q. Jiang, M. Troyanovskaya, G. Jayaraman, and D. P. Healy
Aminopeptidase-A. II. Genomic cloning and characterization of the rat promoter
Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2000; 278(2): R425 - R434.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
L. Song and D. P. Healy
Kidney Aminopeptidase A and Hypertension, Part II : Effects of Angiotensin II
Hypertension, February 1, 1999; 33(2): 746 - 752.
[Abstract] [Full Text] [PDF]